Switch to:

Intercept Pharmaceuticals Inc (ICPT)Ownership Data

Short Interest History (%)

This is the historical short interest of Intercept Pharmaceuticals Inc, as measured by the Short Percentage Of Float.

Date Short Interest
January 30, 201529.5
January 15, 201529.59
December 31, 201427.28
December 15, 201424.04
November 28, 201421.93
November 14, 201421.72
October 31, 201415.35
October 15, 201410.31
September 30, 20149.2
September 15, 20147.75
August 29, 20146.34
August 15, 20146.05
July 31, 20148.07
July 15, 20147.21
June 30, 20148.18
June 13, 20149.71
May 30, 20149.8
May 15, 20147.57
April 30, 20145.65
April 15, 20144.25
March 31, 20146.07
March 14, 20149.48
February 28, 20149.52
February 14, 201410.44
January 31, 20149.41
January 15, 20148.95
December 31, 201313.32
December 13, 20138.64
November 29, 20138.36
November 15, 20135.58
October 31, 20134.64
October 15, 20135.25
September 30, 20133.52
September 13, 20133.68
August 30, 20133.47
August 15, 20133.17
July 31, 20133.15
July 15, 20133.67
June 28, 20132.85
June 14, 20132.76
May 31, 20132.8
May 15, 20133.03
April 30, 20133.46
April 15, 20133.54
March 28, 20133.89
March 15, 20133.74
February 28, 20133.7
February 15, 20133.3
January 31, 20132.47
January 15, 20132.76
December 31, 20123.37
December 14, 20120.27
November 30, 20120.13
November 15, 20120.16
October 31, 20120.05

Institutional Ownership History (%)

This the Institutional Ownership History of Intercept Pharmaceuticals IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
September 30, 201498
August 31, 201497
July 31, 201496
June 30, 201497
May 31, 201498
April 30, 201486
March 31, 201493
February 28, 201495
January 31, 201495
December 31, 201391
November 30, 201361
October 31, 201361
September 30, 201345
August 31, 201347
July 31, 201347
June 30, 201311
May 31, 201338
April 30, 201339
March 31, 201336
February 28, 201336
January 31, 201337
December 31, 201211
November 30, 20128
October 31, 20121

Insider ownership (%)

This is the historical insider ownership of Intercept Pharmaceuticals Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership
January 31, 20153
December 31, 20142
November 30, 20143
October 31, 20143
September 30, 20143
August 31, 20143
July 31, 20143
June 30, 20143
May 31, 20143

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Mr. Mark Pruzanski, M.D.CEO & President491,0322.3%2015-01-05
Mr. David Shapiro, M.D.CMO and EVP - Development18,796less than 0.1%2015-02-17
Ms. Barbara DuncanCFO17,264less than 0.1%2015-01-05
Dr. Luciano Adorini, M.D.Chief Scientific Officer9,411less than 0.1%2015-01-01
Mr. Paolo FundaroDirector8,803less than 0.1%2014-08-09
Dr. Srinivas Akkaraju,M.D.Director7,642less than 0.1%2014-11-11
Rachel McMinnN/A4,923less than 0.1%2014-04-30
Dr. Klaus Veitinger, M.D.Director2,166less than 0.1%2015-02-24
Dr. Luca Benatti, PhDDirector1,292less than 0.1%2014-12-15
Daniel Paul ReganChief Commercial Officer1,264less than 0.1%2015-01-30

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value
Genextra SpA5,938,8902013-12-3130.630.00405,507,409
Fidelity Management and Research Company3,145,5832014-09-3014.750.11744,528,000
OrbiMed Private Investments IV, LP1,654,6032014-05-307.850.00437,013,744
Orbimed Advisors, LLC1,485,0002014-12-316.952.21231,660,000
Carmignac Gestion1,432,0712014-12-316.702.04223,403,000
Fidelity® Select Biotechnology Portfolio1,162,5682014-12-315.441.66181,360,608
Visium Asset Management LLC1,000,4262014-01-095.160.0068,309,087
Hansard EU Carmignac Patrimoine868,2932015-01-314.070.59174,553,197
Capital World Investors860,0002014-12-314.030.04134,160,000
Vanguard Group, Inc.753,6762014-12-313.530.01117,573,000

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK